[
    "{\"step_by_step_thinking\": \"Based on the provided documents, there is evidence of medications being used for post-exposure prophylaxis (PEP) for COVID-19. Document [4] mentions a clinical trial where hydroxychloroquine (HCQ) was offered as PEP to individuals who had direct contact with laboratory-confirmed COVID-19 cases. The study found that HCQ prophylaxis had the potential for the prevention of COVID-19 in at-risk individuals. Additionally, Document [27] mentions non-occupational post-exposure prophylaxis (nPEP) for HIV, which is a similar concept of using medications after exposure to prevent infection. Therefore, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]